Research ArticleOriginal Article
Open Access
Favorable therapeutic response of osteoporosis patients to treatment with intravenous zoledronate compared with oral alendronate
Mohammed M. Al-Bogami, Mohammed A. Alkhorayef, Jonas Bystrom, Olufunso A. Akanle, Nasra K. Al-Adhoubi, Ali S. Jawad and Rizgar A. Mageed
Saudi Medical Journal November 2015, 36 (11) 1305-1311; DOI: https://doi.org/10.15537/smj.2015.11.12731
Mohammed M. Al-Bogami
From the Bone and Joint Research Unit (Al-Bogami, Bystrom, Mageed), William Harvey Research Institute, Barts and the London School of Medicine and Dentistry, Queen Mary University of London, and the Department of Rheumatology (Akanle, Al-Adhoubi, Jawad), the Royal London Hospital, Mile End Road, London, United Kingdom, and the Department of Radiological Sciences (Alkhorayef), College of Applied Medical Sciences, King Saud University, Riyadh, Kingdom of Saudi Arabia
MSc, PhDMohammed A. Alkhorayef
From the Bone and Joint Research Unit (Al-Bogami, Bystrom, Mageed), William Harvey Research Institute, Barts and the London School of Medicine and Dentistry, Queen Mary University of London, and the Department of Rheumatology (Akanle, Al-Adhoubi, Jawad), the Royal London Hospital, Mile End Road, London, United Kingdom, and the Department of Radiological Sciences (Alkhorayef), College of Applied Medical Sciences, King Saud University, Riyadh, Kingdom of Saudi Arabia
MSc, PhDJonas Bystrom
From the Bone and Joint Research Unit (Al-Bogami, Bystrom, Mageed), William Harvey Research Institute, Barts and the London School of Medicine and Dentistry, Queen Mary University of London, and the Department of Rheumatology (Akanle, Al-Adhoubi, Jawad), the Royal London Hospital, Mile End Road, London, United Kingdom, and the Department of Radiological Sciences (Alkhorayef), College of Applied Medical Sciences, King Saud University, Riyadh, Kingdom of Saudi Arabia
MSc, PhDOlufunso A. Akanle
From the Bone and Joint Research Unit (Al-Bogami, Bystrom, Mageed), William Harvey Research Institute, Barts and the London School of Medicine and Dentistry, Queen Mary University of London, and the Department of Rheumatology (Akanle, Al-Adhoubi, Jawad), the Royal London Hospital, Mile End Road, London, United Kingdom, and the Department of Radiological Sciences (Alkhorayef), College of Applied Medical Sciences, King Saud University, Riyadh, Kingdom of Saudi Arabia
BSc, PhDNasra K. Al-Adhoubi
From the Bone and Joint Research Unit (Al-Bogami, Bystrom, Mageed), William Harvey Research Institute, Barts and the London School of Medicine and Dentistry, Queen Mary University of London, and the Department of Rheumatology (Akanle, Al-Adhoubi, Jawad), the Royal London Hospital, Mile End Road, London, United Kingdom, and the Department of Radiological Sciences (Alkhorayef), College of Applied Medical Sciences, King Saud University, Riyadh, Kingdom of Saudi Arabia
MBBS, MRCPAli S. Jawad
From the Bone and Joint Research Unit (Al-Bogami, Bystrom, Mageed), William Harvey Research Institute, Barts and the London School of Medicine and Dentistry, Queen Mary University of London, and the Department of Rheumatology (Akanle, Al-Adhoubi, Jawad), the Royal London Hospital, Mile End Road, London, United Kingdom, and the Department of Radiological Sciences (Alkhorayef), College of Applied Medical Sciences, King Saud University, Riyadh, Kingdom of Saudi Arabia
MBChB, FRCPRizgar A. Mageed
From the Bone and Joint Research Unit (Al-Bogami, Bystrom, Mageed), William Harvey Research Institute, Barts and the London School of Medicine and Dentistry, Queen Mary University of London, and the Department of Rheumatology (Akanle, Al-Adhoubi, Jawad), the Royal London Hospital, Mile End Road, London, United Kingdom, and the Department of Radiological Sciences (Alkhorayef), College of Applied Medical Sciences, King Saud University, Riyadh, Kingdom of Saudi Arabia
PhD, FRCPath
Submit a Response to This Article
Jump to comment:
No eLetters have been published for this article.
In this issue
Favorable therapeutic response of osteoporosis patients to treatment with intravenous zoledronate compared with oral alendronate
Mohammed M. Al-Bogami, Mohammed A. Alkhorayef, Jonas Bystrom, Olufunso A. Akanle, Nasra K. Al-Adhoubi, Ali S. Jawad, Rizgar A. Mageed
Saudi Medical Journal Nov 2015, 36 (11) 1305-1311; DOI: 10.15537/smj.2015.11.12731
Favorable therapeutic response of osteoporosis patients to treatment with intravenous zoledronate compared with oral alendronate
Mohammed M. Al-Bogami, Mohammed A. Alkhorayef, Jonas Bystrom, Olufunso A. Akanle, Nasra K. Al-Adhoubi, Ali S. Jawad, Rizgar A. Mageed
Saudi Medical Journal Nov 2015, 36 (11) 1305-1311; DOI: 10.15537/smj.2015.11.12731
Jump to section
Related Articles
- No related articles found.
Cited By...
- No citing articles found.